News & Updates

High glycaemic burden associated with HCC development and fibrosis progression in patients with CHB + T2D
High glycaemic burden associated with HCC development and fibrosis progression in patients with CHB + T2D
08 Nov 2022
Ovarian reserve damage less with ablation vs cystectomy for endometrioma
Ovarian reserve damage less with ablation vs cystectomy for endometrioma
07 Nov 2022

In the treatment of patients with endometrioma, both ablation and cystectomy cause significant damage to ovarian reserve, although the extent of damage appears to be less with ablation, as shown in a study.

Ovarian reserve damage less with ablation vs cystectomy for endometrioma
07 Nov 2022
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
07 Nov 2022 byJairia Dela Cruz

For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.

Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
07 Nov 2022
Switch to B/F/TAF sustains virologic suppression in adult PLHIV
Switch to B/F/TAF sustains virologic suppression in adult PLHIV
07 Nov 2022 byStephen Padilla

Adult people with HIV-1 (PLHIV) who switched to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) after initially taking dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) or DTG+F/TAF show a consistently high virologic suppression and have few discontinuations over 5 years of follow-up, according to a study presented at the HIV Glasgow 2022 Congress.

Switch to B/F/TAF sustains virologic suppression in adult PLHIV
07 Nov 2022